PDCD1 and neoplasm: While mean tumor growth did not differ between experimental groups (OX40L/PPT, anti-PD-1, OX40L/PPT + anti-PD-1, Figure 4B), individual tumor growth was improved significantly upon combination compared to both OX40L/PPT and anti-PD-1 (Figure 4D).